On May 31, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $10 million to five facilities as part of the first phase to build a California Cell and Gene Therapy Manufacturing Network.

The statewide network is designed to overcome manufacturing bottlenecks that have delayed or stalled development and approval of regenerative medicines.